Showing 1-10 of about 22 articles.
Ligature Therapeutics Pte Ltd
SINGAPORE, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Ligature Therapeutics Pte Ltd, an early-stage biotech company developing small molecule “protein degrader” therapeutics, has announced the close of USD $6...
Atsena Therapeutics
Round was led by Sofinnova Investments with participation from Abingworth, Lightstone Ventures and all existing investors Company expands board of directors and plans to build out team DURHAM, N.C....
Relievant Medsystems, Inc.
MINNEAPOLIS, Oct. 29, 2020 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately-held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), announced today the...
Tizona Therapeutics Inc; Trishula Therapeutics
-- Trishula to Continue Development of TTX-030 in collaboration with AbbVie -- SOUTH SAN FRANCISCO, Calif., Aug. 26, 2020 (GLOBE NEWSWIRE) -- Today Trishula Therapeutics, a clinical stage,...
Cerevance
BOSTON, July 21, 2020 (GLOBE NEWSWIRE) -- Cerevance, a private drug discovery and development company focused on brain diseases, has expanded its Series B financing round, adding $20 million to the...
Cerevance
BOSTON, MA, April 14, 2020 (GLOBE NEWSWIRE) -- Cerevance, a private drug discovery and development company focused on brain diseases, has closed a Series B financing, bringing in $45 million from...
Relievant Medsystems, Inc.
Company to open corporate headquarters in Minneapolis, MN MINNEAPOLIS, June 26, 2018 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately-held medical device company developing minimally-invasive...
Lightstone Ventures
SINGAPORE, May 14, 2018 (GLOBE NEWSWIRE) -- MediSix Therapeutics Pte. Ltd., a development-stage cell therapy company creating novel therapeutics to target T-cell leukemia and lymphoma, today...
SV Health Investors
CAMBRIDGE, Mass., April 12, 2018 (GLOBE NEWSWIRE) -- Boston-area venture capital firms Atlas Venture, F-Prime Capital Partners and SV Health Investors have partnered to create Science 2 Startup, an...
Lightstone Ventures
DUBLIN, Ireland, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Foundry Innovation & Research 1, Ltd. (FIRE1), today announced the close of a Series C financing totaling EUR 40 Million. The financing was led...
Showing 1-10 of about 22 articles.
